BioCentury
ARTICLE | Financial News

CV Therapeutics raises $175 million

March 2, 2000 8:00 AM UTC

CVTX raised $175 million worth of convertible subordinated notes, with a $26.3 million overallotment option. The notes bear 4.75 percent interest, mature in 2007 and convert into CVTX stock at $63.84 ...